Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
RPHC5222528Royalty Pharma plc 3.35% 02-SEP-2051 | 7,36% | 1,22 M | 63,92% | 3,35% | 2051-09-02 | 700 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237919Royalty Pharma plc 3.55% 02-SEP-2050 | 7,18% | 172 K | 67,25% | 3,55% | 2050-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237891Royalty Pharma plc 3.3% 02-SEP-2040 | 6,87% | 8,06 M | 73,10% | 3,30% | 2040-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824522Royalty Pharma plc 5.9% 02-SEP-2054 | 6,36% | 2,85 M | 95,28% | 5,90% | 2054-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5222527Royalty Pharma plc 2.15% 02-SEP-2031 | 5,82% | 1,94 M | 82,53% | 2,15% | 2031-09-02 | 600 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824521Royalty Pharma plc 5.4% 02-SEP-2034 | 5,75% | 10,98 M | 97,83% | 5,40% | 2034-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237916Royalty Pharma plc 2.2% 02-SEP-2030 | 5,61% | 4,96 M | 85,50% | 2,20% | 2030-09-02 | 996,81 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5824520Royalty Pharma plc 5.15% 02-SEP-2029 | 5,18% | 7,72 M | 99,89% | 5,15% | 2029-09-02 | 500 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237354Royalty Pharma plc 1.75% 02-SEP-2027 | 5,04% | 6,46 M | 92,46% | 1,75% | 2027-09-02 | 1 B USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5237914Royalty Pharma plc 1.2% 02-SEP-2025 | 4,90% | 527 K | 97,89% | 1,20% | 2025-09-02 | 999,96 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5035520Royalty Pharma plc 2.2% 02-SEP-2030 | 2,37% | 0 | 98,72% | 2,20% | 2030-09-02 | 3,19 M USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |
RPHC5035516Royalty Pharma plc 1.2% 02-SEP-2025 | 1,30% | 0 | 99,62% | 1,20% | 2025-09-02 | 38 K USD | 1 000,00 USD | 2 000,00 USD | Royalty Pharma Plc |